Drawing for PROTHERACYTES

USPTO serial 79133311

PROTHERACYTES

Reviewed by CopyMark Law Group

Reg. 4574062Status 404
Filing date
Status date
Registration date
Jul 29, 2014
Examiner
COWARD, JEFFERY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROTHERACYTES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan Myers

Jonathan Myers KF Ross, PC5720 Mosholu Ave.PO Box 900Bronx, NY 10471-0900

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations used for cell cultures, cell media cultures, namely, culture media for cultivating human cells, culture media for cell growth, namely, cell growth media for growing cells used for medical biotechnology, biological reagents for molecular biology for medical use, chemical reagents for medical use for biological processes, culture media carriers for medical use, namely, culture media used for rapidly proliferating cell cultures, cellular function activating agents, namely, cell growth factors and hematopoietic factors, serums, namely, human serums for cell culture, antibodies, namely, monoclonal antibodies for detection and treatment of pathologies, all these goods being for medical useSECTION 71 - CANCELLED—
042Services for research and development of new products in the field of biotechnology, scientific analysis services for medical purposes, namely, medical research laboratory services, development of new products for medical research for third partiesSECTION 71 - CANCELLED—
044Medical care and treatment services of myocardial infarction, medical services for cell sampling and isolation, namely, cell collection, isolation and growth services for medical purposes, medical analysis services relating to treatments for individuals, namely, in vitro diagnostic, testing and statistical analysis of the patient status for medical purposes, therapeutic treatments, namely, cell therapy for regenerative medicineSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 1, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 1, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 2, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 8, 2023LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 3, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 24, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 24, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Feb 6, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 22, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 1, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 29, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 27, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 22, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 22, 2015FIMPFINAL DISPOSITION PROCESSED—
Oct 29, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 29, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 13, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 13, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2014GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 23, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 23, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 9, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 9, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 31, 2014ALIEASSIGNED TO LIE—
Mar 20, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2013RFNTREFUSAL PROCESSED BY IB—
Sep 27, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 26, 2013RFRRREFUSAL PROCESSED BY MPU—
Sep 26, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 25, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2013DOCKASSIGNED TO EXAMINER—
Aug 6, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 2, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance